Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Randomized clinical trial of homocysteine level lowering therapy and fractures.

Sawka AM, Ray JG, Yi Q, Josse RG, Lonn E.

Arch Intern Med. 2007 Oct 22;167(19):2136-9. No abstract available.

PMID:
17954810
2.

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.

den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM.

Blood. 2007 Jan 1;109(1):139-44. Epub 2006 Sep 7.

3.
4.

Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine.

Sato Y, Kaji M, Kondo I, Yoshida H, Satoh K, Metoki N.

J Neurol Sci. 2002 Oct 15;202(1-2):65-8.

PMID:
12220694
5.

Homocysteine and venous thrombosis: outline of a vitamin intervention trial.

Willems HP, den Heijer M, Bos GM.

Semin Thromb Hemost. 2000;26(3):297-304.

PMID:
11011847
6.

Summaries for patients. Randomized trial of homocysteine-lowering therapy and risk for venous thromboembolism.

[No authors listed]

Ann Intern Med. 2007 Jun 5;146(11):I22. Epub 2007 Apr 30. No abstract available.

PMID:
17470823
7.

Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE.

Arch Intern Med. 2009 Feb 23;169(4):335-41. doi: 10.1001/archinternmed.2008.574.

8.

Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease.

Kok FJ.

Bibl Nutr Dieta. 2001;(55):189-91. Review. No abstract available.

PMID:
11125576
9.

Can B vitamin therapy help to prevent future vascular events?

Hartsell Z, Budavari AI.

JAAPA. 2007 May;20(5):52, 55. No abstract available.

PMID:
17546945
10.

Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.

Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.

Saudi J Kidney Dis Transpl. 2009 Sep;20(5):779-88.

11.

Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.

Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E; Heart Outcomes Prevention Evaluation 2 Investigators.

Stroke. 2009 Apr;40(4):1365-72. doi: 10.1161/STROKEAHA.108.529503. Epub 2009 Feb 19.

12.

Homocysteine plasma levels after suspension of vitamin treatment.

Santi R, Demicheli M, Contino L, Fiorini T, Levis A.

J Thromb Haemost. 2003 Jun;1(6):1330-2. No abstract available.

13.

Homocysteine trials--clear outcomes for complex reasons.

Loscalzo J.

N Engl J Med. 2006 Apr 13;354(15):1629-32. Epub 2006 Mar 12. No abstract available.

PMID:
16531615
14.

Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.

Levine J, Stahl Z, Sela BA, Ruderman V, Shumaico O, Babushkin I, Osher Y, Bersudsky Y, Belmaker RH.

Biol Psychiatry. 2006 Aug 1;60(3):265-9. Epub 2006 Jan 17.

PMID:
16412989
15.

[Homocysteine lowering with folic acid and B vitamins in vascular disease].

Liakishev AA.

Kardiologiia. 2006;46(5):70. Russian. No abstract available.

PMID:
16858361
16.

Does lowering plasma homocysteine reduce vascular disease risk?

Miller JW.

Nutr Rev. 2001 Jul;59(7):242-4. Review.

PMID:
11475450
17.

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.

Siragusa S, Malato A, Cigna V, Anastasio R, Coco LL, Casuccio A, Ciaccio M.

Thromb Res. 2007;121(1):51-3. Epub 2007 Apr 25. No abstract available.

PMID:
17462714
18.

Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?

Meleady R, Graham I.

Nutr Rev. 1999 Oct;57(10):299-305. Review.

PMID:
10575905
19.

No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.

Spoelstra-de Man AM, Teerlink T, Brouwer CB, Rauwerda JA, Stehouwer CD, Smulders YM.

Clin Endocrinol (Oxf). 2006 May;64(5):495-501.

PMID:
16649966
20.

Determining factors of the response to hyperhomocysteinemia treatment in renal transplant patients.

Díaz JM, Sainz Z, Gich I, Guirado LL, Puig T, Oliver A, Montañés R, Facundo C, Chuy E, Solà R.

Transplant Proc. 2005 Nov;37(9):3785-7.

PMID:
16386538
Items per page

Supplemental Content

Write to the Help Desk